MORN at 52-Week High in Stage 2 Uptrend, No Base Formed

MORN stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 23, 2026 at 00:45 — CANSLIM Research

MORN is trading at 224.42, right at its 52-week high and 59.1% above its yearly low, with price holding above a rising 30-week moving average in a confirmed Stage 2 advance. The market focus is on the absence of any consolidation base, as the stock sits at new highs with no VCP or handle yet formed, leaving the breakout structure unresolved. Sentiment is constructive, with six of eight trend-template checks passing and the relative strength line near a three-month high, though confirmation is still awaited.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.